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Abstract 
Background: Vector control remains the most important tool to prevent malaria transmission. However, it is now 
severely constrained by the appearance of physiological and behavioral insecticide resistance. Therefore, the develop-
ment of new vector control tools is warranted. Such tools could include immunization of blood hosts of vector mos-
quitoes with mosquito proteins involved in midgut homeostasis (anti-mosquito vaccines) or genetic engineering of 
mosquitoes that can drive population-wide knockout of genes producing such proteins to reduce mosquito lifespan 
and malaria transmission probability.
Methods: To achieve this, candidate genes related to midgut homeostasis regulation need to be assessed for their 
effect on mosquito survival. Here, different such candidate genes were silenced through dsRNA injection in the natu-
rally occurring Anopheles arabiensis mosquitoes and the effect on mosquito survival was evaluated.
Results: Significantly higher mortality rates were observed in the mosquitoes silenced for FN3D1 (AARA003032), 
FN3D3 (AARA007751) and GPRGr9 (AARA003963) genes as compared to the control group injected with dsRNA 
against a non-related bacterial gene (LacZ). This observed difference in mortality rate between the candidate genes 
and the control disappeared when gene-silenced mosquitoes were treated with antibiotic mixtures, suggesting that 
gut microbiota play a key role in the observed reduction of mosquito survival.
Conclusions: We demonstrated that interference with the expression of the FN3D1, FN3D3 or GPRGr9 genes causes a 
significant reduction of the longevity of An. arabiensis mosquito in the wild.
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Background
Sub-Saharan Africa hosts some of the most efficient 
malaria vectors, An. gambiae, An. arabiensis and An. 
funestus, and carries the heaviest malaria burden world-
wide. A substantial reduction in malaria related cases 
and deaths have been recorded in the past decade [1]. 
This progress is largely attributable to the scaling-up 
of vector control interventions, such as long-lasting 
insecticide-treated nets (LLINs) and indoor residual 
spraying (IRS), as well as improved diagnostics and effec-
tive treatment using artemisinin-based combination 
therapies [2].
LLINs and IRS impact malaria transmission largely by 
reducing the daily survival rate of mosquitoes that are 
mostly active at night and display strong endophagic 
(seeking blood meals indoors) and endophilic (rest 
indoors following a blood meal) behavior [3, 4]. These 
tools have been more efficient for the endophagic/endo-
philic An. gambiae and An. funestus mosquitoes com-
pared to the exophagic/exophilic An. arabiensis mosquito 
[5–9]. In addition, field studies have reported evidence of 
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behavioral adaptation of An. arabiensis to the LLINs and/
or ITNs as mosquitoes feed earlier and more frequently 
outdoors, and rest more frequently outdoors [7, 10, 11].
Due at least in part to this difference in vector control 
efficacy, a marked shift in vector composition has been 
observed. In east African countries where these vectors 
coexist, An. arabiensis is gradually replacing An. gambiae 
and An. funestus, e.g. in Kenya [12–14] and Tanzania [7, 
15]. Although An. arabiensis is known to be a less effi-
cient vector compared to An. gambiae and An. funestus, 
the inherent resilience of the mosquito to LLINs and IRS 
has been linked to reports of resurgence or stagnation 
in rates of malaria cases and deaths in African countries 
[14]. Therefore, there is a need to develop new comple-
mentary vector control technologies targeting vectors 
that are resilient to the current vector control tools.
Malaria transmission blocking vaccines and mosquito 
population replacement via genetic modification have 
recently become attractive technologies to comple-
ment the existing vector control interventions [16–21]. 
Another novel approach is to reduce the mosquito lifes-
pan by introducing a lethal gene or a pathogen in the 
mosquito population [22, 23]. Along the same lines, the 
mosquito lifespan could be reduced by immunizing pri-
mary mosquito blood hosts (i.e. humans and domestic 
bovids) with mosquito proteins involved in the midgut 
homeostasis. For this approach, candidate genes need to 
be found, which is the topic of this paper. Different An. 
arabiensis genes related to midgut homeostasis were 
screened for their potential to reduce mosquito longev-
ity. Our work was prompted by data showing that shortly 
after a blood meal the number of microbiota in the 
mosquito midgut increases drastically, up to 1000 times 
[24–26], which in normal circumstances triggers immune 
reactions that soon reduce the microbiota number to the 
basal level [27–31]. We hypothesized that by compromis-
ing the immune system the mosquito would no longer be 
able to control the microbiota in the gut, which would 
lead to a shorter lifespan. Previous studies have demon-
strated in a laboratory colony of An. gambiae, that when 
genes encoding putative bacterial receptors such as PGR-
PLC, type III fibronectin domain proteins (FN3Ds includ-
ing FN3D1, FN3D2, FN3D3) and the gustatory receptor 
GPRGr9 were silenced, gut homeostasis was disrupted 
[28, 32]. Here, we investigated the effect of silencing 
some of these genes by RNA interference on longevity in 
naturally occurring An. arabiensis populations.
Methods
Mosquitoes
Adult An. arabiensis mosquitoes were reared from larvae 
and pupae collected from natural breeding sites around 
Jimma, south-west Ethiopia (07°40′00″N, 36°50′00″E). 
Larvae and/or pupae were collected using a 350 ml mos-
quito dipper following the standard larvae collection 
procedure [33, 34]. The collected larvae and pupae were 
transported to an on-site mud-house where the pupae 
were separated from the larvae and transferred into a 
10 ml beaker with water and kept in a mosquito cage with 
a dimension of 24.5 × 24.5 × 24.5  cm3 (Bugdorm-41515; 
Watkins & Doncaster, Leominster, UK) until emergence. 
The remaining larvae were transferred to a plastic tray 
containing water obtained from their natural habitat 
and fed on yeast and tropical fish food. The water was 
changed every 2 days and pupae were collected daily and 
transferred to the adult cage. Emerged adult mosquitoes 
were maintained on 10% sugar solution. Adult females of 
zero to two day old were transported to the experimental 
insectary at Jimma University for double stranded RNA 
(dsRNA) injection.
Gene silencing
Total RNA was extracted from ten field-collected and 
laboratory reared An. arabiensis mosquitoes using TRI-
zol (Invitrogen, Inchinnan, UK) and cleaned with Turbo 
DNase I (Ambion, Huntington, UK). Complementary 
DNA (cDNA) was synthesized by reverse transcribing 
1  μg of the total RNA using a Prime-Script™  1st-strand 
cDNA Synthesis Kit (TaKaRa, Kusatsu, Shangai). Frag-
ments of the five target genes were  amplified by PCR 
using specific gene primers tailed with the short T7 
promoter sequence TAA TAC GAC TCA CTA TAG G 
and the cDNA as a template. The targeted genes were 
FN3D1 (AARA003032), FN3D2 (AARA007751), FN3D3 
(AARA007751), GPRGR9 (AARA003963) and PGRPLC3 
(AARA002982). PCR fragment for the LacZ gene that 
served as a control was synthesized using a plasmid tem-
plate containing the LacZ gene (for full primer sequences 
see Additional file 1: Table S1). DsRNA was synthesised 
from purified PCR products using the TranscriptAid T7 
High Yield Transcription Kit (Thermo Fisher Scientific, 
Waltham, USA). The dsRNA was then purified using 
an RNeasy Mini Kit (Qiagen,  Manchester,  UK), follow-
ing the manufacturer’s protocol. The concentration of 
dsRNA was determined spectrophotometrically by a 
Nanodrop 1000 spectrometer (Thermo Fisher Scientific, 
Wilmington, USA) at 260  nm and adjusted to 3  μg/μl 
using ultra-pure water. Gel electrophoresis (1% TBE aga-
rose) was performed on a sub-sample of the PCR prod-
ucts to confirm that products of the expected size were 
detected for each gene. Zero- to two-days-old An. arabi-
ensis mosquitoes were injected with 69 nl of dsRNA spe-
cific to a target gene or the LacZ control gene following a 
published RNA interference technique [35].
Gene silencing efficiency was measured for each of 
the 5 silenced genes using qrtPCR. Quantification of 
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transcript abundance was performed on cDNA synthe-
sized from total RNA extracted from mosquitoes injected 
with dsRNA 3 days earlier and maintained on 10% sugar 
solution. Fast  SYBR® Green Master Mix Real-Time PCR 
Master Mix (Applied Biosystems, Warrington, UK)  was 
used in the PCR reaction and amplification was detected 
by a 7500 Fast Real-Time PCR system (Applied Bio-
systems). Each target gene was quantified in duplicate. 
The AgS7 gene was used as an internal control. Primer 
sequences are given in Additional file 1: Table S1.
Monitoring of mosquito survival
The dsRNA injected mosquitoes were put into their 
respectively labelled cups. For each gene between 20 
and 30 mosquitoes were injected per replicate. Cups 
with the mosquitoes were placed inside a 2 × 1 × 0.75 m3 
(length × width × height) microclimate regulatory box 
constructed from chipboard. It has a window of 25 cm2 
on each side and the top cover, and was covered with 
metal mesh to allow airflow (Additional file 2: Figure S1). 
The box was placed in a typical rural house. To prevent 
ant attacks, the box was placed on a 50 cm raised stand 
that was dipped halfway into water. It was lined with 
sawdust, 30  cm deep, which was sprinkled daily with 
water and kept closed. The box maintained a humidity 
of 60–70% RH and temperature of 25–28 °C throughout 
the whole study period, hence providing a microclimatic 
condition that resembled the natural resting habitat of 
An. arabiensis mosquitoes. The mosquitoes were offered 
a 10% sugar solution daily and a blood meal every 4 days 
by direct-feeding on a goat. Survival was monitored daily 
for 25  days, starting 24  h post-injection. Six independ-
ent replicates of mosquito injection were performed per 
gene.
Midgut microbiota analysis
A separate experiment was performed to determine 
microbiota load in both blood-fed and sugar-fed mosqui-
toes injected with the specified dsRNA. For each gene, 
between 20 and 30 mosquitoes were injected and trans-
ferred to their corresponding labelled cups. The mosqui-
toes were then kept in a microclimate regulatory box. On 
day 4 post-injection, the mosquitoes were either fed on 
blood or kept on a sugar meal. Twenty-four hours post-
feeding, 5 blood-fed and 5 sugar-fed mosquitoes were 
sampled and their midguts were dissected. Individual 
midguts were homogenized in 100  µl of 4% paraform-
aldehyde (PFA) in phosphate-buffered saline (PBS). The 
number of bacteria was quantified using flow cytometry 
on the 5 pooled midgut samples per replicate [35]. A total 
of 3 replicates of dsRNA injections were carried out per 
gene.
Antibiotic treatment
We tested the effect of reducing/eliminating the mid-
gut microbiota load on the survival of the gene knocked 
down mosquitoes. For this purpose, dsRNA-injected 
mosquitoes were placed in 6 different cups, each cup 
containing 20–30 mosquitoes. The cups were kept in the 
microclimate regulatory box. On the day of dsRNA injec-
tion, the mosquitoes were given a cotton ball soaked in 
an antibiotic cocktail of streptomycin and norfloxacin, 
both at a dose rate of 10 μg/ml in a 10% sugar solution. 
On day 4 post-injection, the mosquitoes were blood-fed 
on a goat. The cotton balls were re-soaked with the anti-
biotic cocktail every fourth day for a period of 12  days 
(on days 4, 8 and 12). The antibiotics/sugar feed was car-
ried out in the morning for about 1  h, and then cotton 
ball was removed from the cups for the next 5 h to starve 
the mosquitoes. The starved mosquitoes were offered a 
blood meal and the cotton ball was replaced on the cups 
after the feed. Mosquito survival was monitored daily for 
25 days starting from 24 h post-injection. For this experi-
ment 5 replicates of dsRNA injection were performed per 
gene.
Data analysis
Data analysis was performed using the statistical soft-
ware package R v.3.3.2. For the gene silencing efficiency 
test, the relative expression of mRNA was calculated. 
The standard curve method was used for real-time 
qPCR quantification analysis. For each test sample, the 
PCR cycle number at which the fluorescent intensity of 
the reaction curve intersects the threshold line, i.e. level 
of detection or the point at which a reaction reaches a 
fluorescent intensity above background levels, known as 
threshold crossing values (Ct-values), was determined 
for the target and reference gene. Additionally, a stand-
ard curve was generated for both the target gene and the 
reference gene in each assay run using serial dilution of 
same template. Then, for each sample, the Ct-value of the 
target or reference gene was standardized using corre-
sponding a standard curve and then the expression level 
of the target gene was normalized to the reference gene 
(AgS7 gene). The relative expression of mRNA of a tar-
get gene was compared between mosquitoes for which 
the target gene was silenced, and mosquitoes injected 
with control dsLacZ by a paired t-test using the rep-
licate as a block factor. Gene silencing efficiency was 
expressed as the ratio of the relative expression of the 
target gene in the dsLacZ injected mosquitoes and the 
target gene silenced mosquitoes. Survival of the target 
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gene and LacZds RNA-injected mosquitoes was depicted 
by Kaplan-Meier survival curves. The effect of silencing 
the different target genes on survival was modeled by the 
Cox proportional hazards frailty model, with replicate 
used as frailty term [36]. The hazard ratio of a target gene 
over the control dsLacZ injection was used as summary 
statistic, together with the median time to death for the 
different gene silenced mosquitoes. To investigate the 
effect of the antibiotics cocktail, the same Cox propor-
tional hazards model was fitted using the hazard ratio 
again as summary statistic. The bacterial counts were first 
log-transformed and then compared by a mixed model 
with replicate as random effect, and treatment, feed and 
the two-way interaction as fixed effects factor. The F-test 
was used to compare the silencing of the different target 
genes and the injection of control dsLacZ. The ratios of 
bacterial counts in the control dsLacZ injections and the 
target gene silencing were used as summary statistics.
Results
Effect of gene silencing on survival
A significant reduction in expression level of mRNA com-
pared to the dsLacZ-injected mosquitoes was achieved 
for the targeted candidate genes FN3D1 (t = -8.36, df = 2, 
P = 0.007), FN3D2 (t = -7.09, df = 2, P = 0.010), FN3D3 
(t = -3.82, df = 2, P = 0.031) and GPRGr9 (t = -6.60, 
df = 2, P = 0.011) but not for PGRPLC3 (t = -1.42, df = 2, 
P = 0.145). The data are presented in Fig. 1.
Mosquito survival following silencing of the target 
genes compared to the control dsLacZ injected mos-
quitoes is depicted as a function of time for the each of 
the above genes in Fig.  2. Significantly higher mortality 
rates were observed for the FN3D1, FN3D3 and GPRGr9 
knocked-down mosquitoes as compared to the control 
group, but not for the FN3D2 and GRPLC3 knocked-
down mosquitoes (Table 1).
A marked reduction in average time to death was 
observed in mosquito groups where target genes were 
silenced compared to dsLacZ-injected controls, e.g. for 
GRPGr9 silenced mosquitoes the median time to death 
was almost halved from 20 (LacZ) to 11 days (Table 2).
Effect of gene silencing on the midgut bacterial count
The global analysis demonstrated that there was no over-
all significant difference between the target gene silenced 
and the dsLacZ-injected mosquitoes with respect to bac-
terial count (F(5,24) = 1.148, P = 0.363). However, there 
was an overall effect of the feed source (F(5,24) = 20.287, 
P < 0.001), i.e. blood-feeding versus sugar-feeding, 
whereas the interaction between the factors was not sig-
nificant (F(5,24) = 1.902, P = 0.131). The ratio of bacteria 
count in blood-fed mosquitoes as compared to sugar-fed 
mosquitoes was 2.13 (95% CI: 1.49–3.06).
When considering the blood-fed mosquitoes alone, no 
statistically significant differences in the bacterial count 
of the target gene silenced and the dsLacZ-injected 
mosquitoes were observed. The ratio of midgut bacte-
rial count of target gene silenced to the dsLacZ-injected 
mosquitoes is presented in Table 3; the ratios for all tar-
get gene silenced mosquitoes compared to the control 
groups (LacZ injected mosquitoes) were above 1, with 
the highest value for FN3D1 equal to 2.66 (95% CI: 0.94–
7.57) but not significantly different from 1 (P = 0.085).
PGRPLC3 FN3D1 FN3D2 FN3D3 GPRGr9
Silenced gene
Ef
fic
ie
nc
y
0
20
40
60
80
10
0
12
0
Fig. 1 The average reduction (vertical line is standard error) in 
expression level of mRNA for the specific knocked-down gene 
mosquitoes as compared to LacZ knocked-down mosquitoes (n = 3)
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Fig. 2 Kaplan-Meier curves depicting the survival rate as a function 
of time for gene-silenced mosquitoes. In the experiment, five test and 
one control genes were considered. The Kaplan-Meier curve for each 
gene is based on six replicates each consisting of 20–30 mosquitoes
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Treatment of mosquitoes with an antibiotics cocktail 
eliminated the gene silencing effect on survival for all 5 
target genes. No statistically significant differences were 
noted in terms of mortality between the target genes 
silenced and the dsLacZ-injected mosquitoes (Table 1).
We also observed that for best performing genes, 
FN3D1 and FN3D3, dsRNA treatment had no effect on 
mosquito fecundity (number of eggs laid/female) or fer-
tility (egg hatchability) of the mosquitoes (Additional 
file 3: Table S2).
Discussion
The scale-up of vector control interventions in conjunc-
tion with early patient diagnosis and therapy has resulted 
in a substantial reduction in malaria-related cases and 
deaths since 2000. However, the newest data suggest that 
this progress is progressively coming to a halt or, in fact, 
being reversed in some countries, indicating that the cur-
rent malaria intervention tools and strategies may have 
reached their maximum capacity [1]. This highlights the 
urgency of developing new tools to complement LLINs 
to achieve the malaria elimination agenda in Africa, 
especially against the exophagic and exophilic An. ara-
biensis mosquito. A viable option against this opportun-
istic feeder species is to challenge different blood hosts 
with whole protein or antigenic peptide generated from 
mosquito itself (i.e. mass vaccination). The resulting host 
antibody is ingested by the mosquito during blood-feed-
ing on an immunised host. This anti-mosquito antibody 
can be designed to target mosquito molecules involved in 
midgut homeostasis to reduce the longevity of the mos-
quito to such an extent that insufficient time remains to 
transmit the Plasmodium parasite.
In order for a mosquito to transmit a pathogen, it must 
acquire a blood meal from an infected person, support 
pathogen replication, dissemination to the salivary glands 
and take a subsequent blood meal from a susceptible 
host; this period is commonly called extrinsic incubation 
period (EIP). The EIP ranges from 10 to 14 days (2 to 6 
gonotrophic cycles in areas of high malaria transmission) 
and a female mosquito must survive longer than the EIP 
to transmit the parasite [37], hence a very small fraction 
of mosquitoes (< 10%) can survive long enough to trans-
mit the pathogen. This underlines the fact that mosquito 
longevity is a critical factor affecting malaria transmis-
sion and provides a basis for guiding vector control strat-
egies [38, 39]. A small reduction in the mean mosquito 
survival period would have a significant impact on the 
disease transmission [40–43].
In the present study, we assessed five midgut-expressed 
genes FN3D1, FN3D2, FN3D3, GPRGr9 and PGRPLC for 
their potential as lifespan-limiting targets in a wild An. 
arabiensis population. Previous studies with An. gam-
biae under laboratory settings have demonstrated that 
the above genes regulate midgut microbiota [28, 32]. 
Unlike these studies, our work focused on the effect of 
those genes on the survival of field-caught An. arabiensis. 
Our experimental mosquitoes were captured as larvae or 
pupae and maintained in an environment simulating the 
mosquito natural resting habitat. They were also allowed 
to blood-feed on a goat every fourth day, mimicking their 
natural habits. We have demonstrated that in these semi-
natural conditions, the reduction of FN3D1, FN3D3 or 
GPRGr9 expression significantly reduces the longevity of 
Table 1 Effect of gene silencing on mosquito survival. The 
second column presents the hazard ratio (HR) of dying between 
a gene knockdown and dsLacZ control. The third column 
presents the hazard ratio of dying between a gene knockdown 
and dsLacZ control when mosquitoes are treated in parallel with 
antibiotics
Gene Hazard ratio (95% CI; P-value)
Without antibiotics With antibiotics
LacZ 1.00 1.00
FN3D1 1.64 (1.17–2.30; P = 0.004) 1.02 (0.75–1.37; P = 0.91)
FN3D2 1.40 (1.00–1.95; P = 0.050) 1.17 (0.86–1.58; P = 0.32)
FN3D3 1.79 (1.28–2.50; P < 0.001) 0.90 (0.67–1.21; P = 0.50)
GPRGr9 2.00 (1.45–2.76; P < 0.001) 0.90 (0.67–1.21; P = 0.47)
PGRPLC3 1.35 (0.97–1.87; P = 0.072) 0.89 (0.66–1.21; P = 0.46)
Table 2 Median time to death in An. arabiensis mosquitoes 
when silenced with genes through injection of gene-specific 
dsRNA
a The upper limit is infinity because some mosquitoes were right censored in 
this treatment group
Gene Median time to death
(days) (95% CI)
LacZ 20 (16– +∞)a
FN3D1 12 (9–17)
FN3D2 13 (10–19)
FN3D3 13 (10–17)
GPRGr9 11 (9–15)
PGRPLC3 16 (13–19)
Table 3 Bacterial count in An. arabiensis mosquitoes silenced 
with genes involved in midgut homeostasis using by 
microinjection of gene-specific dsRNA
Gene Bacterial count ratio (95% CI; P-value)
LacZ 1.00
FN3D1 2.66 (0.94–7.57; P = 0.085)
FN3D2 1.15 (0.40–3.27; P = 0.793)
FN3D3 1.36 (0.48–3.85; P = 0.570)
GPRGr9 2.30 (0.81–6.54; P = 0.136)
PGRPLC3 1.08 (0.38–3.07; P = 0.886)
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the An. arabiensis mosquitoes to an average of 12, 13 and 
11 days, respectively, compared to a 20-day average lon-
gevity of control mosquitoes.
The observed effect on the mosquito survival is prob-
ably linked to the disruption of the mosquito midgut 
homeostasis as the observed effect of gene silencing (par-
ticularly of FN3D1, FN3D3 and GPRGr9) on their sur-
vival was no longer seen when mosquitoes were treated 
with an antibiotic cocktail to eliminate their gut micro-
biota. Our hypothesis that the reduced survival is due to 
the inability of mosquitoes to control their gut microbi-
ota is also supported by other studies [44, 45]. Further-
more, it has been previously demonstrated that FN3Ds 
and GPRGr9 have a specific effect on microbiota of the 
family Enterobacteriaceae [32].
Our results demonstrate that interfering with the 
expression and/or function of these genes reduces the 
mosquito lifespan which in turn will significantly reduce 
malaria transmission. A permanent gene inactivation/
knock-out can be achieved in various ways. A new and 
most promising tool is the recently developed CRISPR/
Cas9-based genome editing methodology and gene-drive 
systems for Anopheles mosquitoes [21, 46, 47]. Recently 
a CRISPR/Cas9-induced somatic gene disruption tech-
nique has been established in An. gambiae [47, 48]. Such 
a knock-out line can be crossed with a germline-Cas9 
strain as described in to generate a germ-line gene-
knockout line which might be released to introgress the 
life-shortening trait into the wild malaria vector popula-
tion [49]. A second approach could be through the immu-
nization of the blood-providing host, whether human or 
domestic animals, with molecules derived from target 
vector proteins that play a role in midgut homeostasis. 
The purified form of such molecules (i.e. antigens) can 
be inoculated into the vertebrate host to induce host 
immune reaction, and ultimately produce specific anti-
bodies. Mosquitoes feeding on the immunized hosts 
would then ingest antibodies that neutralize the function 
of the protein leading to disrupted midgut homeostasis 
and shortened lifespan. It has been previously demon-
strated that An. gambiae-derived anti-midgut monoclo-
nal antibodies significantly reduce vector survivorship 
[50]. This approach is particularly attractive for zoophilic 
mosquitoes such as An. arabiensis. Mosquitoes that have 
taken an infectious blood meal will typically take three 
to four additional blood meals before the completion of 
a sporogonic period as they normally blood-feed every 
2–3  days. This could ensure repeated ingestion of anti-
mosquito antibodies with consequential disruption of 
gut bacterial homeostasis to ultimately induce reduced 
lifespan. This technology can also impact secondary 
malaria vectors including Anopheles rivolorum, Anoph-
eles pharoensis, Anopheles coustani, Anopheles ziemanni 
and Anopheles squamosus that are responsible for about 
5% of total malaria transmission in Africa and are often 
highly zoophilic [51].
As the anti-mosquito vaccine technologies are 
expected to only reduce the long-term survival of vec-
tors of the mosquitoes, female mosquitoes will complete 
some of their gonotrophic cycle. Thus, the technologies 
are expected to have minimum selection pressure induc-
ing resistance [52].
This approach has been successfully used for an anti-
tick vaccine targeting the midgut antigens Bm86 and an 
anti-tick and anti-mosquito vaccine targeting the sub-
olesin/akirin (SUB/AKR) antigens [53–56]. The func-
tional model for the SUB/AKR vaccine involves the 
nuclear factor-kappa B (NF-kB) of vector insects to 
inhibit the Immunodeficiency (Imd) pathway, which is 
important for regulation of the gut microbiota [57, 58].
A major challenge with such protein antigens is that 
they can result in autoimmunity due to molecular mim-
icry as such molecules can possess ‘mimotopes’ that are 
peptides mimicking the antigenic conformation struc-
tures that are recognized by the paratope antibody, lead-
ing to autoimmunity [59].
In the present case, amino acid sequence analysis of 
the An. arabiensis FN3D1 and FN3D3 genes has shown 
the presence of 25–37% sequence identity with proteins 
of some human genes such as the protein tyrosine phos-
phatase receptor type F gene. This level of homology is 
often referred as the ‘twilight zone’ where the structural 
similarity between the target mosquito genes and the 
human genes cannot be ruled out, suggesting a potential 
risk of induction of autoimmune diseases in individuals 
upon immunization with the mosquito genes [60]. For 
instance, an analysis involving over a million sequences 
with known structures showed that at the top cut-off of 
the twilight zone, about 90% of protein pairs were struc-
turally homologous, but the level of homology reduced 
drastically (to < 10%) when the sequence similarity 
between protein pairs was below 25% [59]. On the other 
hand, both mosquito genes have no significant sequence 
similarity in the domestic Bovidae, hence induction of an 
autoimmune reaction in the vaccinated animals is negli-
gible and the protein molecules can be used to develop 
vaccines to immunize the animals with minimum risk.
Conclusions
Eliminating the expression of the midgut proteins 
FN3D1, FN3D3 or GPRGr9 significantly reduces the 
lifespan of naturally occurring An. arabiensis mosqui-
toes reared in field conditions. The effect is probably 
caused by disruption of the mosquito midgut homeo-
stasis through interference with the midgut microbiota, 
eventually hampering the mosquito immuno-metabolic 
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functions. Therefore, these proteins can be good targets 
of mosquito life-shortening interventions, such as anti-
mosquito vaccines or mosquito genetic modification, 
resulting in mosquitoes that can survive long enough 
to complete a gonotrophic cycle but not long enough 
to transmit malaria parasites to a new host. Thus, the 
technologies are expected to have minimum selection 
pressure inducing resistance.
Additional files
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